1766. Sustained Viral Suppression with Dolutegravir and Boosted Darunavir Dual Therapy Among Highly Treatment-Experienced Individuals

BACKGROUND: The use of antiretroviral (ARV) dual therapy for treatment of HIV is increasing; raltegravir with boosted darunavir (bDRV) is recommended in certain clinical situations in DHHS guidelines. Dolutegravir (DTG) with bDRV has not been widely studied. We sought to determine the effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawkins, Kellie, Montague, Brian, Rowan, Sarah, Mclees, Margaret, Beum, Robert, Johnson, Steven C, Gardner, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252975/
http://dx.doi.org/10.1093/ofid/ofy209.151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252975/
http://dx.doi.org/10.1093/ofid/ofy209.151

Ejemplares similares